SciClone Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sciclone Pharma (SCLN) Tops Q1 EPS by 17c
May 10, 2017 4:22 PM EDTSciclone Pharma (NASDAQ: SCLN) reported Q1 EPS of $0.31, $0.17 better than the analyst estimate of $0.14. Revenue for the quarter came in at $42.9 million versus the consensus estimate of $39.94 million.
Revenues: In the first quarter 2017, SciClone reported revenues of $42.9 million, compared to $36.5... More